Aptevo Therapeutics Inc. APVO
Aptevo Therapeutics Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | -919.7% | -174.1% | -638.1% | -126.3% | -224.0% | -368.1% | -1389.8% |
| Net margin | — | — | — | 257.8% | -231.5% | -411.9% | -124.7% | -232.8% | 47.6% | -1125.8% |
| FCF margin | — | — | — | -676.0% | -182.2% | -682.4% | -131.2% | -227.2% | -293.2% | -394.3% |
| Return on assets | -95.5% | -154.8% | -70.1% | 23.5% | -50.3% | -33.1% | -75.7% | -79.5% | 6.0% | -122.4% |
| Return on equity | -149.4% | -507.5% | -142.5% | 44.7% | -2340.2% | -107.0% | -341.6% | -176.6% | 8.5% | -222.3% |
| Debt / equity | — | — | 0.00× | 0.22× | 13.17× | 1.70× | — | 0.63× | 0.19× | 0.36× |
| Current ratio | 3.82 | 1.72 | 2.64 | 3.15 | 1.51 | 3.25 | 0.78 | 2.76 | 5.14 | 3.65 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.